Orange Book product · Generic (ANDA)
GLUCAGON
GLUCAGON
Generic (ANDA)ANDA 214457TE APRX LUPIN
At a glance
Jul 22, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 22, 2025
11 mo ago
Today
Pharmaceutical detail
Active ingredient
GLUCAGON
Strength
1MG/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 214457
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GLUCAGON
- 2025GVOKE VIALDXBrand (NDA)
NDA 212097 · XERIS
- 2019BAQSIMIBrand (NDA)
NDA 210134 · AMPHASTAR PHARMS INC
- 1998GLUCAGONBrand (NDA)
NDA 020928 · LILLY
- 2025GLUCAGONGeneric (ANDA)
ANDA 218813 · CIPLA
- 2024GLUCAGONGeneric (ANDA)
ANDA 204468 · MYLAN LABS LTD
- 2020GLUCAGONGeneric (ANDA)
ANDA 208086 · AMPHASTAR PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
